The rationale and design of TransCon Growth Hormone for the treatment of growth hormone deficiency

The rationale and design of TransCon Growth Hormone for the treatment of growth hormone deficiency

The fundamental challenge of developing a long-acting growth hormone (LAGH) is to create a more convenient growth hormone (GH) dosing profile while retaining the excellent safety, efficacy and tolerability of daily GH. With GH receptors on virtually all cells, replacement therapy should achieve the...

Full description

Bibliographic Details
Main Authors: Kennett Sprogøe, Eva Mortensen, David B Karpf, Jonathan A Leff
Format: Article
Language:English
Published: Bioscientifica 2017-10-01
Series:Endocrine Connections
Subjects:
long-acting growth hormone
TransCon GH
Online Access:http://www.endocrineconnections.com/content/6/8/R171.full

Similar Items

Similar Items